BIOalternatives specializes in cellular and molecular pharmacology for the Food, Beverage, and Nutrition industry. BIOalternatives provides services to support the early stages of drug discovery. BIOalternatives has special expertise in skin cell and tissue models, epithelial cell and tissue models, neural cell and tissue models, mesenchymal cell and tissue models, and blood-derived immune-inflammatory cells.
BIOalternatives was founded fifteen years ago to offer a personalized approach for R&D in biology. This remains our core business and our highly trained scientists use cutting-edge technologies to provide you the best solution to outsource your projects, ...view more
BIOalternatives was founded fifteen years ago to offer a personalized approach for R&D in biology. This remains our core business and our highly trained scientists use cutting-edge technologies to provide you the best solution to outsource your projects, avoiding the heavy and time consuming R&D phases. view less
BIOalternatives' know-how is presented in a synthetic catalog of validated assays briefly described and illustrated and directly extracted from our IT system.
High Content Screening (HCS) is a powerful approach for a fast compound selection from your libraries (chemical entities, crude extracts, actives, etc) focusing on a specific biological activity or target in cell cultures (primary cells, cell lines, co-cu...view more
High Content Screening (HCS) is a powerful approach for a fast compound selection from your libraries (chemical entities, crude extracts, actives, etc) focusing on a specific biological activity or target in cell cultures (primary cells, cell lines, co-cultures). view less
Additionally to our integrated services for pharmacology, our laboratory analyzes your own biological samples using efficient and fully recognized molecular biology methods.
Safety assessment of compounds is an important criterion before expensive preclinical and clinical studies. In order to predict early cytotoxicity or specific cellular impacts, BIOalternatives provides services for toxicity and safety profiling in a wide ...view more
Safety assessment of compounds is an important criterion before expensive preclinical and clinical studies. In order to predict early cytotoxicity or specific cellular impacts, BIOalternatives provides services for toxicity and safety profiling in a wide range of normal cells or cell lines (blood and immune cells, neurons, epithelial and mesenchymal cells). view less
Upgrade to a premium Prospector account to filter by ingredient properties and view compliance highlights. These features can help you make smarter formulation decisions with instant access to:
Search by physical and chemical properties. Personal Care & Cosmetics only.
We're sorry, but the industry you have selected is not currently available in your chosen language. You may choose a language below to continue to this industry or close this dialog above.